Clinical Trial Update: Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updating sorafenib combined with low-dose cytarabine in older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome (Phase 1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Cytarabine (Low-Dose) (cytarabine)
• Sorafenib (Sorafenib)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: COMPLETED